Drug
isatuximab
Marketed as SARCLISA.
Generic name
isatuximab
Brand names
SARCLISA
First FDA approval
2020-03-02
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761113 | SARCLISA | 2020-03-02 | SANOFI AVENTIS US |
Manufacturers
SANOFI AVENTIS US
Frequently asked questions
When was isatuximab FDA approved?
Earliest FDA approval on record: 2020-03-02.
What brand names are sold as isatuximab?
SARCLISA.
Sources
Appeal a isatuximab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com